articleTop 1% cited

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors

The American Journal of Gastroenterology · 2011 · Vol. 107(4) · pp. 569–577

Shuichiro Shiina✉(The University of Tokyo)Ryosuke Tateishi(The University of Tokyo)Toru Arano(The University of Tokyo)Koji Uchino(The University of Tokyo)Kenichiro Enooku(The University of Tokyo)Hayato Nakagawa(The University of Tokyo)Yoshinari Asaoka(The University of Tokyo)Takahisa Sato(The University of Tokyo)Ryota Masuzaki(The University of Tokyo)Yuji Kondo(The University of Tokyo)Tadashi Goto(The University of Tokyo)Haruhiko Yoshida(The University of Tokyo)Masao Omata(The University of Tokyo)Kazuhiko Koike(The University of Tokyo)

View via DOI Publisher page

Abstract

RFA could be locally curative for HCC, resulting in survival for as long as 10 years, and was a safe procedure. RFA might be a first-line treatment for selected patients with early-stage HCC.

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Endoplasmic Reticulum Stress and DiseaseMedicineHepatocellular carcinomaRadiofrequency ablationAblationCarcinomaInternal medicineOncologyRadiology

MeSH terms

Agedalpha-FetoproteinsFemaleFollow-Up StudiesCarcinoma, HepatocellularHumansLiver NeoplasmsMaleNeoplasm Recurrence, LocalNeoplasm StagingPrognosisProspective StudiesProtein PrecursorsProthrombinReoperation

Citations

714

FWCI

17.52

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Hepatocellular carcinoma